Down-regulation of RIP1 by 2-deoxy-D-glucose sensitizes breast cancer cells to TRAIL-induced apoptosis

European Journal of Pharmacology

Volumn 705, Issue 1-3, 2013, Pages 26-34

  Huang, Ying Ying ^a   Liu, Hao ^a   Li, Yang ^a   Pu, Long Jian ^a   Jiang, Chen Chen ^b   Xu, Jin Cheng ^a   Jiang, Zhi Wen ^a  

^a BENGBU MEDICAL COLLEGE   (China)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

2 DG; Apoptosis; Breast cancer; Caspase; RIP1; TRAIL

Indexed keywords

CASPASE 3; DEATH RECEPTOR 5; DEOXYGLUCOSE; GLUCOSE REGULATED PROTEIN 78; INHIBITOR OF APOPTOSIS PROTEIN 1; PROCASPASE 8; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; DEOXYGLUCOSE; DOWN-REGULATION; HEAT-SHOCK PROTEINS; HUMANS; NUCLEAR PORE COMPLEX PROTEINS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84875315397     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.02.005     Document Type: Article

References (33)

1. A. Ashkenazi Directing cancer cells to self-destruct with pro-apoptotic receptor agonists Nat. Rev. Drug Discov. 7 2008 1001 1012
2. A. Ashkenazi, and V.M. Dixit Death receptors: signaling and modulation Science 281 1998 1305 1308
3. A. Ashkenazi, R.C. Pai, S. Fong, S. Leung, D.A. Lawrence, S.A. Marsters, C. Blackie, L. Chang, A.E. McMurtrey, A. Hebert, L. DeForge, I.L. Koumenis, D. Lewis, L. Harris, J. Bussiere, H. Koeppen, Z. Shahrokh, and R.H. Schwall Safety and antitumor activity of recombinant soluble Apo2 ligand J. Clin. Invest. 104 1999 155 162
4. M.J. Bertrand, S. Milutinovic, K.M. Dickson, W.C. Ho, A. Boudreault, J. Durkin, J.W. Gillard, J.B. Jaquith, S.J. Morris, and P.A. Barker cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination Mol. Cell 30 2008 689 700
5. J.L. Bodmer, N. Holler, S. Reynard, P. Vinciguerra, P. Schneider, P. Juo, J. Blenis, and J. Tschopp TRAIL receptor-2 signals apoptosis through FADD and caspase-8 Nat. Cell Biol. 2 2000 241 243
6. L.H. Chen, C.C. Jiang, K.A. Kiejda, Y.F. Wang, R.F. Thorne, X.D. Zhang, and P. Hersey Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response Carcinogenesis 28 2007 2328 2336
7. Z. Chen, W. Lu, C. Garcia-Prieto, and P. Huang The Warburg effect and its cancer therapeutic implications J. Bioenerg. Biomembr. 39 2007 267 274
8. F. Cossu, E. Mastrangelo, M. Milani, G. Sorrentino, D. Lecis, D. Delia, L. Manzoni, P. Seneci, C. Scolastico, and M. Bolognesi Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2 Biochem. Biophys. Res. Commun. 378 2009 162 167
9. W. Declercq, T. Vanden Berghe, and P. Vandenabeele RIP kinases at the crossroads of cell death and survival Cell 138 2009 229 232
10. N. Festjens, T. Vanden Berghe, and P. Vandenabeele Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response Biochim. Biophys. Acta 1757 2006 1371 1387
11. N. Festjens, T. Vanden Berghe, S. Cornelis, and P. Vandenabeele RIP1, a kinase on the crossroads of a cell's decision to live or die Cell Death Differ. 14 2007 400 410
12. P. Hersey, and X.D. Zhang How melanoma cells evade trail-induced apoptosis Nat. Rev. Cancer 1 2001 142 150
13. M. Holcik, and R.G. Korneluk XIAP, the guardian angel Nat. Rev. Mol. Cell Biol. 2 2001 550 556
14. C.C. Jiang, L.H. Chen, S. Gillespie, K.A. Kiejda, N. Mhaidat, Y.F. Wang, R. Thorne, X.D. Zhang, and P. Hersey Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response Cancer Res. 67 2007 5880 5888
15. A.V. Kuznetsov, R. Margreiter, A. Amberger, V. Saks, and M. Grimm Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death Biochim. Biophys. Acta 1813 2011 1144 1152
16. D. Lawrence, Z. Shahrokh, S. Marsters, K. Achilles, D. Shih, B. Mounho, K. Hillan, K. Totpal, L. DeForge, P. Schow, J. Hooley, S. Sherwood, R. Pai, S. Leung, L. Khan, B. Gliniak, J. Bussiere, C.A. Smith, S.S. Strom, S. Kelley, J.A. Fox, D. Thomas, and A. Ashkenazi Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions Nat. Med. 7 2001 383 385
17. H. Liu, C.C. Jiang, C.J. Lavis, A. Croft, L. Dong, H.Y. Tseng, F. Yang, K.H. Tay, P. Hersey, and X.D. Zhang 2-Deoxy-d-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2 Mol. Cancer 8 2009 122
18. D.J. Mahoney, H.H. Cheung, R.L. Mrad, S. Plenchette, C. Simard, E. Enwere, V. Arora, T.W. Mak, E.C. Lacasse, J. Waring, and R.G. Korneluk Both cIAPI and cIAP2 regulate TNFalpha-mediated NF-kappaB activation Proc. Natl. Acad Sci. USA 105 2008 11778 11783
19. B. Nachmias, Y. Ashhab, and D. Ben-Yehuda The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer Semin. Cancer Biol. 14 2004 231 243
20. S. Nagata Apoptosis by death factor Cell 88 1997 355 365
21. D. Pauleit, G. Stoffels, A. Bachofner, F.W. Floeth, M. Sabel, H. Herzog, L. Tellmann, P. Jansen, G. Reifenberger, K. Hamacher, H.H. Coenen, and K.J. Langen Comparison of (18)F-FET and (18)F-FDG PET in brain tumors Nucl. Med. Biol. 36 2009 779 787
22. H. Pelicano, D.S. Martin, R.H. Xu, and P. Huang Glycolysis inhibition for anticancer treatment Oncogene 25 2006 4633 4646
23. M. Pellegrini, S. Bath, V.S. Marsden, D.C. Huang, D. Metcalf, A.W. Harris, and A. Strasser FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells Blood 106 2005 1581 1589
24. P.E. Porporato, S. Dhup, R.K. Dadhich, T. Copetti, and P. Sonveaux Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review Front Pharmacol. 2 2011 49
25. Y. Sasaki, M. Minamizawa, A. Ambo, S. Sugawara, Y. Ogawa, and K. Nitta Cell-penetrating peptide-conjugated XIAP-inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation FEBS J. 275 2008 6011 6021
26. J.H. Song, M.C. Tse, A. Bellail, S. Phuphanich, F. Khuri, N.M. Kneteman, and C. Hao Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells Cancer Res. 67 2007 6946 6955
27. M.R. Sprick, M.A. Weigand, E. Rieser, C.T. Rauch, P. Juo, J. Blenis, P.H. Krammer, and H. Walczak FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 Immunity 12 2000 599 609
28. H. Walczak, and P.H. Krammer The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems Exp. Cell Res. 256 2000 58 66
29. H. Walczak, R.E. Miller, K. Ariail, B. Gliniak, T.S. Griffith, M. Kubin, W. Chin, J. Jones, A. Woodward, T. Le, C. Smith, P. Smolak, R.G. Goodwin, C.T. Rauch, J.C. Schuh, and D.H. Lynch Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat. Med. 5 1999 157 163
30. R. Weindruch, K.P. Keenan, J.M. Carney, G. Fernandes, R.J. Feuers, R.A. Floyd, J.B. Halter, J.J. Ramsey, A. Richardson, G.S. Roth, and S.R. Spindler Caloric restriction mimetics: metabolic interventions J. Gerontol.: A Biol. Sci. Med. Sci. 56 2001 20 33
31. X. Wen, Z.Q. Lin, B. Liu, and Y.Q. Wei Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer Cell Prolif. 45 2012 217 224
32. X.D. Zhang, A. Franco, K. Myers, C. Gray, T. Nguyen, and P. Hersey Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma Cancer Res. 59 1999 2747 2753
33. X.D. Zhang, J.J. Wu, S. Gillespie, J. Borrow, and P. Hersey Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin Clin. Cancer Res. 12 2006 1355 1364